Neurocognitive assessment and pharmacotherapy towards prevention of schizophrenia: What can we learn from first episode psychosis?

Tomiki Sumiyoshi*, Yasuhiro Kawasaki, Michio Suzuki, Yuko Higuchi, Shimako Nishiyama, Masayoshi Kurachi

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Research into first episode psychosis (FEP) is a growing field in psychiatry. In this paper, the authors provide an overview of neurocognitive findings and therapeutic approaches indicated for patients with FEP. Focus will be placed on evidence from neuropsychological assessment and brain imaging of electrophysiological activities, as well as the ability of some psychotropic drugs, such as second generation antipsychotics, to improve functional outcome. Efforts to identify biological signals characteristic of FEP are expected to facilitate early intervention into schizophrenia and related disorders.

Original languageEnglish
Pages (from-to)57-64
Number of pages8
JournalClinical Psychopharmacology and Neuroscience
Volume6
Issue number2
StatePublished - 2008/08

Keywords

  • Antipsychotic drugs
  • Cognition
  • EEG
  • Early intervention
  • Event-related potentials
  • Neuroprotection
  • Prevention
  • Prodrome
  • Schizophrenia
  • Serotonin

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Neurocognitive assessment and pharmacotherapy towards prevention of schizophrenia: What can we learn from first episode psychosis?'. Together they form a unique fingerprint.

Cite this